Validation of absolutely quantitated Ki67 and <scp>cyclinD1</scp> protein levels for prognosis of Luminal‐like breast cancer patients-Reference-Cited by-同舟云学术

Validation of absolutely quantitated Ki67 and cyclinD1 protein levels for prognosis of Luminal‐like breast cancer patients

Published:2022-07-12 Issue:8 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Yu Guohua¹,Lyu Jiahong²,Li Yalun³,Zhang Yunyun²,Lyu Yan²,Zhang Wengfeng²,Zhang Jianbo²,Cai Bocheng²,Zhang Jiandi²^ORCID,Tang Fangrong²

Affiliation:

1. Laboratory of Molecular Pathology, Department of Pathology Affiliated Yantai Yuhuangding Hospital of Qingdao University Yantai China

2. Yantai Quanticision Diagnostics, Inc., A Division of Quanticision Diagnostics, Inc of US Yantai China

3. Department of Breast Surgical Oncology Affiliated Yantai Yuhuangding Hospital of Qingdao University Yantai China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24601

Reference20 articles.

1. Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer

2. Cyclin D as a therapeutic target in cancer

3. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

4. RE: Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group

5. Response to Zhang and Yang

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Expression of Cyclin D1 and p16 in Invasive Breast Carcinoma and Its Association with Clinicopathological Parameters;Indian Journal of Surgical Oncology;2024-07-06

2. ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients;Frontiers in Oncology;2023-03-10